Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Burt

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Delivery|August 27, 2016
Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guideTal Burt, Christy S John, Jon L Ruckle, et al.
Journal of Clinical Research & Bioethics|January 16, 2015
Clinical Research Environment in India: Challenges and Proposed SolutionsTal Burt, Pooja Sharma, Savita Dhillon, et al.
Human Psychopharmacology|November 20, 2004
Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorderMeir Steiner, Christer Allgulander, Arun Ravindran, et al.
Journal of Clinical Research & Bioethics|January 6, 2015
Ethics Standards (HRPP) and Public Partnership (PARTAKE) to Address Clinical Research Concerns in India: Moving Toward Ethical, Responsible, Culturally Sensitive, and Community-Engaging Clinical ResearchTal Burt, Yogendra K Gupta, Nalin Mehta, et al.
Nature Reviews. Drug Discovery|September 9, 2020
Phase 0/microdosing approaches: time for mainstream application in drug development?Tal Burt, Graeme Young, Wooin Lee, et al.
International Clinical Psychopharmacology|August 13, 2005
A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in JapanKunitoshi Kamijima, Tomifusa Kuboki, Hiroaki Kumano, et al.
International Journal of Geriatric Psychiatry|January 13, 2004
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezilSanford I Finkel, Jacobo E Mintzer, Maurice Dysken, et al.
Alternatives to Laboratory Animals : ATLA|January 19, 2019
Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug developmentTal Burt, Le Thuy Vuong, Elizabeth Baker, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 20, 2003
Does antidepressant therapy improve cognition in elderly depressed patients?P Murali Doraiswamy, K Ranga Rama Krishnan, Thomas Oxman, et al.
Plos One|July 23, 2013
PARTAKE survey of public knowledge and perceptions of clinical research in IndiaTal Burt, Savita Dhillon, Pooja Sharma, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Delivery|August 27, 2016
Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guideTal Burt, Christy S John, Jon L Ruckle, et al.
Journal of Clinical Research & Bioethics|January 16, 2015
Clinical Research Environment in India: Challenges and Proposed SolutionsTal Burt, Pooja Sharma, Savita Dhillon, et al.
Human Psychopharmacology|November 20, 2004
Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorderMeir Steiner, Christer Allgulander, Arun Ravindran, et al.
Journal of Clinical Research & Bioethics|January 6, 2015
Ethics Standards (HRPP) and Public Partnership (PARTAKE) to Address Clinical Research Concerns in India: Moving Toward Ethical, Responsible, Culturally Sensitive, and Community-Engaging Clinical ResearchTal Burt, Yogendra K Gupta, Nalin Mehta, et al.
Nature Reviews. Drug Discovery|September 9, 2020
Phase 0/microdosing approaches: time for mainstream application in drug development?Tal Burt, Graeme Young, Wooin Lee, et al.
International Clinical Psychopharmacology|August 13, 2005
A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in JapanKunitoshi Kamijima, Tomifusa Kuboki, Hiroaki Kumano, et al.
International Journal of Geriatric Psychiatry|January 13, 2004
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezilSanford I Finkel, Jacobo E Mintzer, Maurice Dysken, et al.
Alternatives to Laboratory Animals : ATLA|January 19, 2019
Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug developmentTal Burt, Le Thuy Vuong, Elizabeth Baker, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 20, 2003
Does antidepressant therapy improve cognition in elderly depressed patients?P Murali Doraiswamy, K Ranga Rama Krishnan, Thomas Oxman, et al.
Plos One|July 23, 2013
PARTAKE survey of public knowledge and perceptions of clinical research in IndiaTal Burt, Savita Dhillon, Pooja Sharma, et al.
Pageof 3